Largest US Study On HIV Treatment In Women
Tibotec Therapeutics Clinical Affairs, a division of Ortho Biotech Clinical Affairs, LLC, announced recently the initiation of the largest clinical study conducted to date in therapy-experienced adult women with HIV to evaluate gender differences in response to an HIV medication. GRACE (Gender, Race And Clinical Experience), a multi-center, open-label Phase IIIb trial, will compare gender differences in the efficacy, safety and tolerability of PREZISTA (darunavir) tablets administered with other antiretroviral agents over a 48-week therapy period. The study also will explore racial differences in therapy outcomes........
This entry was posted
on Friday, September 29th, 2006 at 4:46 pm and is filed under Nutritional facts.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.